ACT Genomics Overview

  • Founded
  • 2014

Founded
  • Status
  • Private

  • Latest Deal Type
  • Series D

  • Investors
  • 12

ACT Genomics General Information

Description

Provider of cancer molecular information services designed to rewrite the existing model of diagnostic, treatment, and monitoring. The company's cancer molecular information services implement next-generation sequencing and multiplex molecular testing, coupled with bioinformatics tools, curated proprietary databases and data visualization technologies, enabling oncologists to address the key challenges in cancer treatments.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Services
Other Industries
Biotechnology
Primary Office
  • 3 Floor, Number 345
  • Xinhu 2nd Road
  • Taipei City, Neihu District 114
  • Taiwan
+886 02 0000 0000

ACT Genomics Timeline

2019202020212022
Financing Round

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ACT Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series D) 17-Dec-2020 0000 Completed Profitable
3. Early Stage VC 26-Sep-2018 000.00 0000 Completed Startup
2. Early Stage VC (Series B) 01-May-2016 $12.5M $20.5M Completed Startup
1. Early Stage VC (Series A) 13-Feb-2015 $8M $8M Completed Startup
To view ACT Genomics’s complete valuation and funding history, request access »

ACT Genomics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of cancer molecular information services designed to rewrite the existing model of diagnostic, treatment, and m
Other Healthcare Services
Taipei City, Taiwan
0000
00000000000 0000

000000

por incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation
0000000000000
South Plainfield, NJ
000 As of 0000
0000 0000-00-00
000000&0

000000

p ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dol
0000000000 00000000 (0000000000)
Cambridge, United Kingdom
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ACT Genomics Competitors (20)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genewiz Formerly VC-backed South Plainfield, NJ 000 000000&0
0000000000 Corporation Cambridge, United Kingdom
00000 00000000 Private Equity-Backed Aliso Viejo, CA 000 000000&0
00000 000000 00000 Venture Capital-Backed Nashik, India 000 00000 0000000000 0 00000
000000000 00000000 Formerly VC-backed Billerica, MA 00 00000 000000&0 00000
You’re viewing 5 of 20 competitors. Get the full list »

ACT Genomics Executive Team (6)

Name Title Board Seat Contact Info
PJ Hsueh Chief Operating Officer
Hua Chien Chen Ph.D Co-Founder and Chief Executive Officer
Victor Chan Chief Financial Officer
Shu-Jen Chen Ph.D Co-Founder & Chief Scientific Officer
Alan Yung Chief Commercial Officer
You’re viewing 5 of 6 executive team members. Get the full list »

ACT Genomics Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Aflac Ventures Corporate Venture Capital Minority 000 0000 000000 0
Drive Catalyst Corporate Venture Capital Minority 000 0000 000000 0
JAFCO Asia Venture Capital Minority 000 0000 000000 0
Kyoto University Innovation Capital Venture Capital Minority 000 0000 000000 0
CLSA Capital Partners PE/Buyout Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »

ACT Genomics Investments & Acquisitions (3)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 0000000 24-Aug-2021 00000 0000 Laboratory Services (Healthcare) 000 00000
00 0000000000 06-Jul-2021 0000000000 Biotechnology 000 00000
ACTmed 01-Mar-2017 Joint Venture Biotechnology
To view ACT Genomics’s complete investments and acquisitions history, request access »

ACT Genomics Subsidiaries (1)

Company Name Industry Location Founded
00 00000000000 Biotechnology Rhyl, United Kingdom 0000
To view ACT Genomics’s complete subsidiaries history, request access »